Peter M. Hecht - 25 Mar 2025 SCHEDULE 13D/A Report for CYCLERION THERAPEUTICS, INC. Common Stock, no par value (CYCN)

Filing Manager
Peter M. Hecht
Reporting Manager
Peter M. Hecht
Security
CYCLERION THERAPEUTICS, INC. Common Stock, no par value
Symbol
CYCN
Shares outstanding
3,684,896 shares
Disclosed Ownership
1,028,086 shares
Ownership
28%
Form type
SCHEDULE 13D/A
Filing time
28 Mar 2025, 21:47:19 UTC
Date of event
25 Mar 2025
SEC
View on sec.gov

Quoteable Key Fact

"Peter M. Hecht disclosed 28% ownership in CYCLERION THERAPEUTICS, INC. Common Stock, no par value (CYCN) on 25 Mar 2025."

Quick Takeaways

  • Peter M. Hecht filed SCHEDULE 13D/A for CYCLERION THERAPEUTICS, INC. Common Stock, no par value (CYCN).
  • Disclosed ownership: 28%.
  • Date of event: 25 Mar 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 28 Mar 2025, 21:47.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Peter M. Hecht 28% 1,028,086 1,028,086 0 /s/ Peter M. Hecht Peter M. Hecht 0001478485